Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 14:50
Evidence Synthesis
KMSMEDI's 27.74% is accelerating, up from 2.1%.
The company's .1% also shows an accelerating trend, rising from 2.01%. On the other hand, revenue growth year-over-year is accelerating at .7%, down from -96.1%. The daily volume has increased to 2000 shares, while the close price remains unchanged at 132.8 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 27.74 % | 2.1 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 2.1 % | 2.01 | ▲ |
| REVENUE_GROWTH_YOY | -8.7 % | -96.1 | ▲ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 2,000 shares | 32 | ▲ |
| CLOSE_PRICE | 132.8 INR | 132.8 | - |